Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001183740-22-000047
Filing Date
2022-03-02
Accepted
2022-03-01 18:48:11
Documents
11
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 f6k-20220301drug.htm 6-K 7134
2 NOTICE OF MEETING AND RECORD DATE ex991.htm EX-99.1 8711
3 ex991_1.jpg GRAPHIC 1974
4 NOTICE OF ANNUAL GENERAL MEETING RELATING TO THE ANNUAL GENERAL MEETING OF SHARE ex992.htm EX-99.2 13363
5 INFORMATION CIRCULAR RELATING TO THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO B ex993.htm EX-99.3 239800
6 PROXY CARD RELATING TO ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MARC ex994.htm EX-99.4 901
7 ex994_1.jpg GRAPHIC 104867
8 ex994_2.jpg GRAPHIC 84949
9 REQUEST FOR ANNUAL AND INTERIM FINANCIAL STATEMENTS AND MD&A ex995.htm EX-99.5 5369
10 ex995_1.jpg GRAPHIC 17229
11 ex995_2.jpg GRAPHIC 80978
  Complete submission text file 0001183740-22-000047.txt   676076
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 22700470
SIC: 2834 Pharmaceutical Preparations